Position in GRFS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$2,077
New position
Shares Held
259
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Annis Gardner Whiting Capital Advisors, LLC holds $18,574,820 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
19,005 | $4,826,699 | |
| 2 | AMGN |
Amgen Inc
|
7,897 | $2,859,661 | |
| 3 | NVO |
Novo Nordisk A S
|
58,858 | $2,821,652 | |
| 4 | LLY |
ELI LILLY & Co
|
1,713 | $2,054,623 | |
| 5 | ABBV |
AbbVie Inc.
|
6,840 | $1,721,217 | |
| 6 | PFE |
Pfizer Inc
|
61,427 | $1,479,162 | |
| 7 | BIIB |
Biogen Inc.
|
5,233 | $1,130,641 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,338 | $1,071,433 |
All Filings in GRFS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,077 | 259 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||